Skip to main content

Table 3 Characteristics of Lymph Nodes and Masses (N = 328)

From: Effect of chlorhexidine mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial

 

Chlorhexidine Mouthrinse

(n = 159)

Usual Care

(n = 169)

P Value

LN stations/masses

 

 2R

14 (8.8)

17 (10.1)

 

 2L

0 (0.0)

1 (0.6)

 

 3P

0 (0.0)

1 (0.6)

 

 4R

40 (25.2)

42 (24.9)

 

 4L

29 (18.2)

29 (17.2)

 

 7

39 (24.5)

43 (25.4)

 

 10R

2 (1.3)

1 (0.6)

 

 10L

4 (2.5)

1 (0.6)

 

 11R

17 (10.7)

22 (13.0)

 

 11L

10 (6.3)

11 (6.5)

 

 Mass

4 (2.5)

1 (0.6)

 

Number of aspirations per LN/mass

0.30

  ≤ 1

89 (56.0)

85 (50.3)

 

  > 1

70 (44.0)

84 (49.7)

 

Ultrasound characteristics

 

 Size > 1 cm

56 (35.2)

38 (22.5)

0.01

 Round shape

21 (13.2)

20 (11.8)

0.71

 Distinct margin

123 (77.4)

122 (72.2)

0.28

 Central hilar structure

29 (18.2)

46 (27.2)

0.05

 Calcification

16 (10.1)

29 (17.2)

0.06

 Heterogeneous echogenicity

36 (22.6)

20 (11.8)

0.01

 Coagulation necrosis sign

10 (6.3)

6 (3.6)

0.25

 Cystic lesion

0 (0.0)

0 (0.0)

 

Gross visual appearance of aspirates

 

 Pus-like material

8 (5.0)

2 (1.2)

0.06

Cytopathology of LN/mass (n = 327)a

0.14

 Malignant

39 (24.5)

30 (17.9)

 

 Benign

120 (75.5)

138 (82.1)

 
  1. Data are presented as number (%). LN Lymph node
  2. aEndobronchial ultrasound-guided transbronchial needle aspiration for one LN failed to acquire cytopathologic specimens